EXPERIENCE IN FOLICULAR LYMPHOMA TRANSFORMED IN A TERTIARY HOSPITAL IN THE ERA RITUXIMAB

被引：0
|
作者：
Lopez Oreja, I [1 ]
Zumalde Murua, A. [2 ]
Perez Santaolalla, E. [1 ]
Sirvent Azurmendi, M. [1 ]
Segues Merino, N. [1 ]
Urretabizkaia Barallorbe, I [1 ]
Artola Urain, T. [1 ]
Otero Longo, I [1 ]
Arambarri Larranaga, A. [1 ]
Arrizabalaga Fernandez, H. [1 ]
Caminos Altuna, N. [1 ]
Gonzalez Gonzalez, C. [1 ]
Ceberio Echepia, I [1 ]
Araiz Ramirez, M. [1 ]
机构：
[1] Hosp Univ Donostia, San Sebastian, Spain
[2] Univ Basque Country, Bilbao, Spain
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-100
引用
收藏
页码：347 / 348
页数：2
相关论文
共 50 条
  • [1] PROGNOSIS IN FOLICULAR LYMPHOMA TRANSFORMED TO DIAGNOSIS IN THE RITUXIMAB ERA
    Sara, Alonso-Alvarez
    Miguel, Alcoceba
    Laura, Magnano
    Marcio, Andrade-Campos
    Guillermo, Rodriguez
    Juan Manuel, Sancho
    Santiago, Mercadal
    Antonio, Salar
    Francesc, Garcia-Pallarols
    Reyes, Arranz
    Maria Jose, Terol
    Antonia, Rodriguez
    de Villambrosia Sonia, Gonzalez
    Beatriz, Antelo
    Lourdes, Lopez
    Silvia, Monsalvo
    Silvia, Novelli
    Erik, De Cabo
    Maria Stefania, Infante
    Emilia, Pardal
    Miguel, Canales
    Marcos, Gonzalez
    Alejandro, Martin
    Armando, Lopez-Guillermo
    Dolores, Caballero M.
    HAEMATOLOGICA, 2016, 101 : 217 - 218
  • [2] EXTENDED MAINTENANCE WITH RITUXIMAB IN FOLICULAR LYMPHOMA: EXPERIENCE OF A CENTER
    Campuzano Saavedra, V
    Sevil Puras, F.
    Duenas Perez, A.
    Aguilar, F. C.
    HAEMATOLOGICA, 2018, 103 : 228 - 229
  • [3] PET-CAT IN FOLICULAR LYMPHOMA:? IS IT USEFUL TO DISCRIMINATE HISTOLOGICAL GRADE ?. EXPERIENCE OF A TERTIARY HOSPITAL
    Arguello de Tomas, M.
    Domingo, A.
    Rotger, A.
    Menarguez Palanca, F. J.
    Diaz Crespo, F.
    Diez Martin, J. L.
    Bastos Oreico, M.
    HAEMATOLOGICA, 2019, 104 : 156 - 157
  • [4] RITUXIMAB AS A MAINTENANCE TREATMENT IN FOLICULAR LYMPHOMA
    Cervantes Diana, Buenasmananas
    Primo Carmen, Calle
    Luque Mar, Nebro
    Ruiz Belen, Hernandez
    HAEMATOLOGICA, 2016, 101 : 361 - 361
  • [5] Survival of patients with transformed lymphoma in the rituximab era
    Hany R. Guirguis
    Matthew C. Cheung
    Eugenia Piliotis
    David Spaner
    Neil L. Berinstein
    Kevin Imrie
    Liying Zhang
    Rena Buckstein
    Annals of Hematology, 2014, 93 : 1007 - 1014
  • [6] Survival of patients with transformed lymphoma in the rituximab era
    Guirguis, Hany R.
    Cheung, Matthew C.
    Piliotis, Eugenia
    Spaner, David
    Berinstein, Neil L.
    Imrie, Kevin
    Zhang, Liying
    Buckstein, Rena
    ANNALS OF HEMATOLOGY, 2014, 93 (06) : 1007 - 1014
  • [7] DURATION OF THE RESPONSE IN PATIENTS WITH FOLICULAR LYMPHOMA (FL) AFTER THE SUCESSIVE PHASES OF TREATMENT IN THE ERA OF RITUXIMAB
    Laura, Magnano
    Alfredo, Rivas-Delgado
    Ivan, Dlouhy
    Jordina, Rovira
    Alejandra, Martinez-Trillos
    Eva, Gine
    Julio, Delgado
    Tycho, Baumann
    Blanca, Gonzalez
    Antonio, Martinez
    Olga, Balague
    Neus, Villamor
    Elias, Campo
    Armando, Lopez-Guillermo
    HAEMATOLOGICA, 2016, 101 : 10 - 11
  • [8] Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013
    Gleeson, Mary
    Hawkes, Eliza A.
    Peckitt, Clare
    Wotherspoon, Andrew
    Attygalle, Ayoma
    Sharma, Bhupinder
    Du, Yong
    Ethell, Mark
    Potter, Mike
    Dearden, Claire
    Horwich, Alan
    Chau, Ian
    Cunningham, David
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 1805 - 1813
  • [9] MAINTENANCE WITH QUARTERLY RITUXIMAB AFTER THE FIRST LINE CHEMOTHERAPY IN THE FOLICULAR LYMPHOMA - EXPERIENCE OF A CENTER
    Oliveira, F.
    Moreira, A.
    Pavao, C.
    Viveiros, C.
    Araujo, A. L.
    Fraga, C.
    HAEMATOLOGICA, 2017, 102 : 352 - 352
  • [10] TRANSFORMED FOLLICULAR LYMPHOMA TREATMENT OUTCOME DURING THE RITUXIMAB ERA
    Elhassadi, E.
    Flavin, R.
    Browne, P.
    Hayden, P.
    Higgins, L.
    Vanderberghe, E.
    HAEMATOLOGICA, 2014, 99 : 706 - 706
12345